Answers are grounded in this paper and cite their sources.
Meta-analysis reveals that probiotic metabolites modulate inflammatory biomarkers in obesity, suggesting novel therapeutic targets for chronic inflammation.
: This revealed the immunometabolic importance of the gut microbiota and suggested that probiotic metabolites could be potential therapeutic targets for obesity-induced inflammation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: